Previous 10 | Next 10 |
Deals and Financings InnoCare Pharma of Beijing priced its Hong Kong IPO at the top end of its proposed range to raise $288 million at a $1 billion valuation, according to insiders. The company develops immunotherapies for cancer and autoimmune diseases. It has three molecules in clinical ...
Image source: The Motley Fool. Zai Lab Limited (NASDAQ: ZLAB) Q4 2019 Earnings Call Mar 19, 2020 , 8:30 a.m. ET Operator Continue reading
Zai Lab Limited (ZLAB) Q4 2019 Earnings Conference Call March 19, 2020 8:30 AM ET Company Participants Billy Cho – Chief Financial Officer Samantha Du – Founder and Chief Executive Officer Tao Fu – President and Chief Operating Officer Jonathan Wang –...
Healthcare Pulse A new reality dawned as the stock market entered a bear market. It wasn't a tiptoe moment for the bear. The market simply plummeted into a bear market canyon. Just from March 4 to March 12, in about a week, the S&P 500 and Nasdaq declined 20% or more. The healthcare ...
The following slide deck was published by Zai Lab Limited in conjunction with their 2019 Q4 earnings Read more ...
-- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT SHANGHAI, China and SAN FRANCISCO, March 19, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for t...
The China National Medical Products Administration has accepted Zai Lab's (NASDAQ: ZLAB ) supplemental New Drug Application (sNDA) for ZEJULA (niraparib) as a maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer wh...
SHANGHAI, China and SAN FRANCISCO, March 16, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the China National Medical Products Administration (NMPA) has accepted its supplemental New Dru...
Deals and Financings Bio-Thera Solutions (SHA: 688177) of Guangzhou priced its IPO on Shanghai's STAR Board to raise $241 million at a valuation of almost $2 billion. The offering, which placed 60 million shares at RMB32.76 each, was reported to be 3,225 times oversubscribed. Bio-Thera lis...
SHANGHAI, China and SAN FRANCISCO, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB), a China and U.S.-based innovative commercial-stage biopharmaceutical company, today announced that Dr. Samantha Du, Founder and Chief Executive Officer, will be pre...
News, Short Squeeze, Breakout and More Instantly...
First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study Zai Lab Limited (NASDAQ: Z...
Manuscript represents the first publication from China’s gynecology oncology field to be published in Cell Publication highlights first-time learnings about the landscape of ovarian cancer microenvironment stratified by HRD and how a PARP inhibitor perturbs it Data suggest ...
2024-07-05 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...